Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation

Cancer Research

Volumn 58, Issue 4, 1998, Pages 599-603

  Ford, James M ^a   Baron, Elinor L ^a   Hanawalt, Philip C ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; EXCISION REPAIR; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION; WART VIRUS;

APOPTOSIS; CELL CYCLE; CELL LINE; DNA REPAIR; DNA-BINDING PROTEINS; FIBROBLASTS; GENES, P53; GENES, VIRAL; HUMANS; PAPILLOMAVIRIDAE; TETRAHYDROFOLATE DEHYDROGENASE; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

EID: 0032520060     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
2. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
3. Ford, J. M., and Hanawalt, P. C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA, 92: 8876-8880, 1995.
4. Ford, J. M., and Hanawalt, P. C. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem., 272: 28073-28080, 1997.
5. Ford, J. M., and Hanawalt, P. C. Role of DNA excision repair gene defects in the etiology of cancer. Curr. Top. Microbiol. Immunol., 221: 47-70, 1997.
6. Bohr, V. A., Smith. C. A., Okumoto, D. S., and Hanawalt, P. C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell, 40: 359-369, 1985.
7. Mellon, I., Bohr, V. A., Smith, C. A., and Hanawalt, P. C. Preferential DNA repair of an active gene in human cells. Proc. Natl. Acad. Sci. USA, 83: 8878-8882, 1986.
8. Mellon, I., Spivak, G., and Hanawalt, P. C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell, 51: 241-249, 1987.
9. Maki, C. G., Huibregtse, J. M., and Howley, P. M. In vivo ubiquitination and proteasome mediated degradation of p53. Cancer Res., 56: 2649-2654, 1996.
10. Maki, C. G., and Howley, P. M. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell. Biol., 17: 355-363, 1997.
11. Scheffner, M., Werness, J. M., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
12. Huibregtse, J. M., Scheffner, M., and Howley, P. M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus type 16 or 18. EMBO J., 10: 4129-4135, 1991.
13. Scheffner, M., Huibregtse, J. M., Vierstra, R., and Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75: 495-505, 1993.
14. Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. V., Han, S. M., Lorincz, A. T., Hedrick, L., and Cho, K. R. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA, 90: 3988-3992, 1993.
15. Smith, M. L., Chen, I. T., Zhan, Q., O'Connor, P. M., and Fornace, A. J., Jr. Involvement of the p53 tumor suppressor in repair of U.V.-type DNA damage. Oncogene, 10: 1053-1059, 1995.
16. Li, C., Nagasawa, H., Tsang, N., and Little, J. B. Radiation-induced irreversible G(0)/G(1) block is abolished in human diploid fibroblasts transfected with the human papilloma virus E6 gene: implication of the p53-Cip1/WAF1 pathway. Int. J. Oncol., 6: 233-236, 1995.
17. Yu, Y., Li, C., and Little, J. B. Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene, 14: 1661-1667, 1997.
18. 1, cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev., 10: 934-947, 1996.
19. Mori, T., Nakane, M., Hattori, T., Matsunaga, T., Ihara, M., and Nikaido, O. Simultaneous establishment of monoclonal antibodies specific for either cyclobutane pyrimidine dimer or (6-4) photoproduct from the same mouse immunized with ultraviolet-irradiated DNA. Photochem. Photobiol., 54: 225-232, 1991.
20. Smith, M. L., Kontny, H. U., Zhan, Q., Sreenath, A., O'Connor, P. M., and Fornace, A. J., Jr. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to U.V.-irradiation or cisplatin. Oncogene, 13: 2255-2263, 1996.
21. Havre, P. A., Yuan, J., Hedrick. L., Cho, K. R., and Glazer, P. M. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res., 55: 4420-4424, 1995.
22. Fan, S., Smith, M. L., Rivet, D. J., Duba, D., Zhan, Q., Kohn, K. W., Fomace, A. J., Jr., and O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res., 55: 1649-1654, 1995.
23. Hawkins, D. S., Demers, G. W., and Galloway, D. A. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res., 56: 892-898, 1996.
24. Slichenmyer, W. J., Nelson, W. G., Slebos, R. J., and Kastan, M. B. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res., 53: 4164-4168, 1993.
25. Caelles, C., Helmberg, A., and Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (Lond.), 370: 220-223, 1994.